20 Minutes

AUSCEP 2023 Impact Report

The 2023 AUSCEP Impact report is a celebration of the completion of our inaugural program, where 125 clinicians across VIC, NSW & WA took part in a 12 month program to further their healthcare innovation & deliver tangible, real world impacts.
AUSCEP 2023 Impact Report
Written by
Published on
December 21, 2023

Embark on a journey through the groundbreaking strides in healthcare innovation as we unveil the highlights of the 2023 AUSCEP Impact report.

This report is a testament to the success of our inaugural program, bringing together 125 clinicians from VIC, NSW, and WA. Over the course of 12 months, these healthcare trailblazers immersed themselves in a transformative program, leaving an indelible mark on the industry and delivering tangible, real-world impacts. Discover the stories of dedication, ingenuity, and collaboration that have shaped the future of healthcare. The 2023 AUSCEP Impact report not only reflects the achievements of these clinicians but also serves as a beacon for the possibilities that lie ahead in healthcare innovation.

Ready to delve into the forefront of healthcare transformation? Download the full 2023 AUSCEP Impact report and be inspired by the incredible strides made by clinicians across Australia:

Our blog

Latest blog posts

Missed out on recent AUSCEP news? Check out our most recent stories below.
Participant Journeys

Bridging the Healthcare Information Gap: A Vision for Patient-Centred Access

Dr Yoni Goldenberg reflects on the transformative potential of DrQR to enhance medical record accessibility, promoting patient autonomy and efficiency in healthcare delivery.
Peter Birch
October 9, 2023
4 minute read
Participant Journeys

Navigating Lymphoedema: The Journey from Chronic Swelling to Empowered Self-Management

The management of lymphoedema is dominated by inefficient, paper-based processes which presents an opportunity for digital platforms to play a transformative role to improve health outcomes
Peter Birch
October 9, 2023
6 minute read